XML 47 R30.htm IDEA: XBRL DOCUMENT v3.24.3
Shareholders' Equity (Tables)
12 Months Ended
Jun. 30, 2024
Shareholders' Equity [Abstract]  
Schedule of Warrants and Options A summary of the share options granted to non-employee consultants under the Plans by Pluri Inc. and its Subsidiary is as follows:
   Year ended June 30, 2023 
   Number
(**)
   Weighted
average
exercise price
   Weighted
average
remaining
contractual
terms
(in years)
   Aggregate
intrinsic
value price
 
Share options outstanding at beginning of period   11,381   $10.56    7.05    44 
Share options forfeited   (3,281)  $18.32    
-
    
-
 
Share options outstanding at end of the period   8,100   $7.44    6.24    29 
Share options exercisable at the end of the period   7,475   $6.69    6.06    29 
Share options unvested   625   $16.00    8.44   $- 
Share options vested and expected to vest at the end of the period   8,100   $7.44    6.24    29 
   Year ended June 30, 2024 
   Number
(**)
   Weighted
average
exercise price
   Weighted
average
remaining
contractual
terms
(in years)
   Aggregate
intrinsic
value price
 
Share options outstanding at beginning of period   8,100   $7.44    6.24    29 
Share options granted   9,375   $4.40    4.56    13 
Share options outstanding at end of the period   17,475   $5.80    4.87   $42 
Share options exercisable at the end of the period   8,100   $7.41    5.24   $29 
Share options unvested   9,375   $4.40    4.56    13 
Share options vested and expected to vest at the end of the period   17,475   $5.80    4.87   $42 
(**) See note 1d regarding reverse share split

 

   Year ended June 30, 2023 
   Number
(**)
   Weighted
average
exercise price
   Weighted
average
remaining
contractual
terms
(in years)
 
Share options outstanding at the beginning of the period   
-
   $
-
    
-
 
Share options granted   229,353   $15.20    3.47 
Share options outstanding at the end of the period   229,353   $15.20    3.47 
Share options exercisable at the end of the period   114,676   $15.20    3.47 
Share options unvested   114,677   $15.20    3.47 
Share options vested and expected to vest at the end of the period   229,353   $15.20    3.47 
   Year ended June 30, 2024 
   Number
(**)
   Weighted
average
exercise price
   Weighted
average
remaining
contractual
terms
(in years)
 
Share options outstanding at the beginning of the period   229,353   $15.20    3.47 
Share options granted   12,500   $6.08    6.73 
Share options forfeited   (1,562)  $6.08    
-
 
Share options outstanding at the end of the period   240,291   $14.82    2.42 
Share options vested and exercisable at the end of the period   240,291   $14.82    2.42 
Schedule of Activity Related to Unvested RSUs Granted The following table summarizes the activity related to unvested RSUs granted to employees and directors under the Plans by Pluri Inc. and its Subsidiary, for the years ended June 30, 2024 and 2023:
   Year ended June 30, 
   2024   2023 
   Number (**) 
Unvested at the beginning of period   207,199    241,877 
Granted   395,327    41,853 
Forfeited   (132,400)   (6,424)
Vested   (116,992)   (70,107)
Unvested at the end of the period   353,134    207,199 
Expected to vest after the end of period   319,533    205,072 
The following table summarizes the activity related to unvested RSUs and RS granted to non-employee consultants under the Plans by Pluri Inc. and its Subsidiary for the years ended June 30, 2024 and 2023:
   Year ended June 30, 
   2024   2023 
   Number (**) 
Unvested at the beginning of period   2,500    5,157 
Granted   27,270    
-
 
Vested   (24,968)   (2,657)
Unvested at the end of the period   4,802    2,500 
(**) See note 1d regarding reverse share split
Schedule of Expenses Related to RSUs Granted Compensation expenses related to RSUs granted to employees and directors by Pluri Inc. and its Subsidiary were recorded as follows:
   Year ended June 30, 
   2024   2023 
Research and development expenses  $316   $55 
General and administrative expenses   1,258    2,150 
   $1,574   $2,205 
Compensation expenses related to RSUs and RS granted to consultants by Pluri Inc. and its Subsidiary were recorded as follows:
   Year ended June 30, 
   2024   2023 
Research and development expenses  $
-
   $1 
General and administrative expenses   170    204 
   $170   $205 
Schedule of Warrants and Options Summary of the Company’s warrants and options:
   Year ended June 30, 2024 
Warrants / Options  Weighted average exercise
price per
share
   Options and
warrants
for common
shares (**)
   Options and
warrants
exercisable
for common
shares (**)
   Weighted
average
remaining
contractual
terms
(in years)
 
Warrants:  $8.24    697,485    697,485    1.55 
   $8.40    258,565    258,565    1.82 
   $8.48    29,688    29,688    1.47 
   $8.72    16,875    16,875    1.49 
   $8.96    16,875    16,875    1.50 
Total warrants        1,019,488    1,019,488      
                     
Options:  $5.80    17,475    8,100    4.87 
   $8.96    41,853    41,853    2.04 
   $12.48    62,500    62,500    2.25 
   $16.64    62,500    62,500    2.25 
   $20.80    62,500    62,500    2.25 
   $6.08    10,938    10,938    6.73 
Total options        257,766    248,391      
Total warrants and options        1,277,254    1,267,879      
(**) See note 1d regarding reverse share split